1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Page references a 2026 MDIC application cycle but no specific deadline date was visible. A dedicated application page exists ('2026 Medical Device Innovation Challenge Application') but was not fetched.
"CNYBAC Medical Device Innovation Challenge" is currently closed and not accepting applications.
CNYBAC Medical Device Innovation Challenge is sponsored by Central New York Biotech Accelerator (CNYBAC). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Upstate Medical University **Please note: the application window for the 2026 program is now closed. We will seek applications for 2027 in January. ** To date, 45 teams have participated in MDIC since its inception in 2017 and have achieved impressive milestones during and after graduation.
MDIC program creator and CNYBAC Executive Director, Kathi Durdon, provides more information about the program during a WCNY interview. **MDIC Applications** are accepted January through March 1 each year. Those that are commercializing a Class I, II or III medical device and **fully complete** the MDIC application are sent an Innovation Law Center Supplemental Questionnaire to be completed by March 15.
Only those applicants that fill out both forms will move on to the selection process. Applications are reviewed through due diligence performed by The Innovation Law Center (ILC) College of Law, Syracuse University. They provide a short list of applicants for the MDIC Review Committee to select up to five teams.
The program starts for the selected teams with commercialization research performed by the ILC in June/July. Research can include patent landscape, competitive analysis, device classification/predicate product(s) review, and freedom to operate. Teams are assigned 3+ mentors targeted to their goal setting.
Monthly meetings are held with the team and their mentors as a group in August through December (1 hour/month).
**CNYBAC Medical Device Innovation Challenge (MDIC)Two-step Application Process** Step 1: Confirm eligibility/Complete Initial MDIC Application by March 1 To be eligible to apply, you have an early stage medical device you plan to commercialize or license/sell your technology and: * You are a US-based innovation team/startup company. * Are in early-to-mid stage development of a medical device per**FDA medical device definition**.
* Your innovation is reduced to practice and you are able to apply for a patent, have a provisional patent filed, or patent approved. * You know your FDA device classification and regulatory pathway or intend to include this as a goal within the program if selected. * You have completed an I-Corps customer discovery program or have interest in participating.
* You have not disclosed information about your innovation, such as through a presentation or publication prior to patent filing. * Agree to meet the requirements of the program: attend all monthly mentor meetings, actively participate in action items advised by mentors, and attend CNYBAC virtual education events (most are recorded/you can access at your convenience). * Prior year applicants not selected are welcome to apply.
* If you meet the eligibility, complete the MDIC Application as of January 1 and return by March 1 to durdonk@upstate. edu. Step 2: Complete Innovation Law Center (ILC) Supplemental Questionnaire by March 15 * Those applicants which meet eligibility will be sent the ILC Supplemental Questionnaire to complete by March 15 - sent to: durdonk@upstate.
edu. * Only those applicants who have completed the ILC Supplemental Questionnaire will be considered for MDIC review. * The MDIC Review Committee will select teams in May/June.
Those selected are required to complete an MDIC Agreement. We do not take any equity/all IP is owned by the applicant. * CNYBAC covers the costs of student-based commercialization research for each selected team performed by the Innovation Law Center, **NYS Science and Technology Law Center**, Syracuse University College of Law.
* Mentorship: mentors are assigned to each team based on individual team goals. Hour-long virtual mentor meetings are held monthly, scheduled Mon-Fri, 8:00 a. m.
- 3:00 p. m. EST starting in August.
* Selected teams gain coordinated access to **SUNY Upstate Medical University research partners**and **Core Facilities. ** * We provide targeted resource assistance and networking opportunities throughout the program. * We help connect teams to innovation ecosystem opportunities/resources.
For questions or more information call 315-464-9290 or email durdonk@upstate. edu
According to the current listing, eligibility includes: Program is hosted by CNY Biotech Accelerator at Upstate Medical University in Syracuse, NY; specific eligibility criteria not visible on the page. Confirm the full requirements in the official notice before applying.
The current listing shows $50,000 - $250,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The most recent published deadline was April 30, 2026, which has passed. This is an annual program, so a new cycle should follow. Check the funder's website for the next application window.
CNYBAC Medical Device Innovation Challenge is funded by Central New York Biotech Accelerator (CNYBAC). Verify program details on the funder's official page before applying.
This opportunity targets applicants in New York. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
The Hewlett Foundation's Emerging Technology and Security Initiative commits $20 million a year through 2031 across AI, biotechnology, and quantum computing security. Its 2026 exploratory grants went to thirteen named institutions with no open call. For organizations outside that list, the path in runs through a specific set of moves — and the five-year term starting in 2027 is the window.
Read articleNSF has $8.8 billion appropriated and is holding roughly $1 billion of it in a central account earmarked for a White House initiative called Grand Research Challenges. Core programs cannot reach the money. Roughly 400 peer-reviewed, recommended proposals are sitting at the Office of Award Management. Here is what the mechanism actually is, why it is different from the terminations story, and how to plan a submission calendar around it.
Read articleNSF 26-517 replaces the core solicitations of Environmental Biology, Integrative Organismal Systems and Molecular and Cellular Biosciences with a single directorate-wide opportunity. Proposals are accepted anytime, sorted centrally by NSF rather than targeted by the PI, and reorganized under three inquiry areas. Here is what the $280 million actually buys, why the loss of program targeting cuts both ways, and what to do before the September 16 webinar.
Read article